It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

Emma Walmsley has also been busy shaking up the company and has replaced 50 top managers, around 40% of the company’s management. Pfizer said in October that it is considering selling its ...

Two Senate committees are expected to question Robert F. Kennedy Jr. on how his disproven views of science and medicine ...

LONDON - The European Commission has authorized the use of Vocabria and Rekambys, a long-acting injectable regimen, for adolescents living with HIV-1, ViiV Healthcare, majority-owned by GSK (NYSE: GSK ...

There can’t be many people in the UK who enjoyed a £2.5 million pay rise this year – but that’s what GlaxoSmithKline boss Emma Walmsley got following a strong year for sales at the drugs giant.

The company said under a collaboration with the university it would invest £50m over three years to find out whether cancers ...

Some health professionals have spoken out about President Donald Trump’s nomination of Robert F. Kennedy, Jr., for Secretary of Health and Human Services ...

Ana Botin, executive chair of Spanish bank Santander has denied reports that the company is considering leaving the British ...

Last year she was named the 15 th most powerful woman in the world by Forbes, coming between Emma Walmsley, CEO of GlaxoSmithKline and Safra Catz, the CEO of Oracle. Santander has around 14 ...

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top ...